Skip to content
HowShorted

Arcadia Biosciences, Inc. short interest in 2020

In 2020, Arcadia Biosciences, Inc.'s disclosed short interest ran from 8.57% of shares outstanding on 15 Jan 2020 to 1.40% on 31 Dec 2020, a change of -7.17 percentage points. The year's high was 8.67% on 14 Feb 2020 and its low 0.89% on 15 Dec 2020, averaging 4.91% across 23 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 6.19 days on 30 Oct 2020. Full history: Arcadia Biosciences, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Arcadia Biosciences, Inc. in 2020

2020 in figures

Start of year
8.57% (15 Jan 2020)
End of year
1.40% (31 Dec 2020)
Change
-7.17 pp
High
8.67% (14 Feb 2020)
Low
0.89% (15 Dec 2020)
Average
4.91%
Highest days to cover
6.19 (30 Oct 2020)
SEC filings marked
8

Every report in 2020

Arcadia Biosciences, Inc. short interest in 2020
SettlementShort interestDays to coverFilings since previous
15 Jan 20208.57%4.08
31 Jan 20207.60%1.59
14 Feb 20208.67%4.99
28 Feb 20207.06%2.89
13 Mar 20206.23%3.00
31 Mar 20206.44%2.8910-K filed, results (8-K)
15 Apr 20205.68%5.62
30 Apr 20205.83%3.04
15 May 20206.94%2.8810-Q filed, results (8-K)
29 May 20203.69%1.51
15 Jun 20203.36%1.41
30 Jun 20203.41%1.00
15 Jul 20203.99%3.51
31 Jul 20204.90%2.91
14 Aug 20204.11%2.3010-Q filed, results (8-K)
31 Aug 20204.52%3.06
15 Sep 20204.25%4.22
30 Sep 20205.10%1.22
15 Oct 20205.02%2.70
30 Oct 20203.37%6.19
13 Nov 20201.85%1.42results (8-K), 10-Q filed
15 Dec 20200.89%1.00
31 Dec 20201.40%1.00

See also: Arcadia Biosciences, Inc.'s full history · most shorted US stocks of 2020 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.